(1 reference)-
- 抗原 See all ILP-2 (BIRC8) 抗体
- ILP-2 (BIRC8) (Baculoviral IAP Repeat-Containing 8 (BIRC8))
-
抗原表位
- AA 2-13
- 适用
- 人, 大鼠, 小鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This ILP-2 antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 交叉反应
- 小鼠, 大鼠
- 产品特性
- Purified IgG
- 纯化方法
- Purified
- 免疫原
- Synthetic peptide TGYEARLITFGT corresponding to amino acids 2-13 of human ILP-2.
- 亚型
- IgG
-
anti-Baculoviral IAP Repeat-Containing 8 (BIRC8) (AA 1-236) antibody
BIRC8 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Baculoviral IAP Repeat-Containing 8 (BIRC8) antibodyBIRC8 适用: 人, 大鼠, 小鼠 WB, IF, EIA 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1.0 mg/mL
-
-
: "Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family." in: Molecular and cellular biology, Vol. 21, Issue 13, pp. 4292-301, (2001) (PubMed).
-
: "Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family." in: Molecular and cellular biology, Vol. 21, Issue 13, pp. 4292-301, (2001) (PubMed).
-
-
You are here:
